Quality of life and influencing factors of postoperative accelerated rehabilitation of esophageal cancer patients.
10.3760/cma.j.cn112152-20200602-00514
- VernacularTitle:食管癌患者加速康复术后生活质量水平及影响因素分析
- Author:
Yuan YU
1
;
Min LI
1
;
Ran KANG
1
;
Nuo Xiao Xuan WANG
1
;
Xin Zhe LIU
1
;
Qing Miao ZHU
1
;
Jun CAO
1
Author Information
1. Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
- Publication Type:Journal Article
- Keywords:
Enhanced recovery after surgery;
Esophageal neoplasms;
Influencing factor;
Quality of life
- MeSH:
Esophageal Neoplasms/surgery*;
Fatigue;
Humans;
Quality of Life;
Surveys and Questionnaires
- From:
Chinese Journal of Oncology
2022;44(4):341-346
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the quality of life and its influencing factors of enhanced recovery after surgery (ERAS) of esophageal cancer patients. Methods: The quality of life of 134 esophageal cancer patients was assessed using the quality of life assessment scale (EORTC QLQ-C30) developed by the European Cancer Research and Treatment Organization. Student's t test, One-way ANOVA and multiple linear regression statistical methods were used to analyze the effects of sociodemographic and clinical characteristics on patients' quality of life. Results: The overall score of quality of life (74.00) was lower than that of the general population (75.30). However, the scores of emotion and cognition in function dimension (93.97 and 95.77) were better than those of the general population (82.80 and 86.50). The results of fatigue, pain, insomnia and constipation in symptom dimension (14.18, 10.94, 11.69 and 5.72) were better than those of the general population (28.80, 20.50, 20.40 and 10.70). The pathological stage, body mass index and dietary were independent influencing factors for the quality of life of patients with esophageal cancer (P<0.05). Conclusions: ERAS can partially improve the quality of life of esophageal cancer patients. More attention should be paid to the esophageal cancer patients after surgery and take targeted measures to improve their quality of life.